Research collaboration leverages Pattern's ProSpectral™ multi-disease hyperspectral diagnostics research platform Potentially ushers in a new era of early detection cancer screening REDMOND, WA, August 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Pattern and [...]
Targets high-grade serous ovarian cancer, the most common and deadliest form of gynecologic cancer Underscores potential of Pattern Discovery Engine™ to uncover novel therapeutic combinations for hard-to-treat cancers REDMOND, WA, July 30, 2024 -- Pattern Computer®, Inc. ("Pattern" or [...]
New paper on sensing research collaboration with national labs available on medRxiv Hyperspectral sensing shown to enable agnostic reagent-free diagnostics Study addresses clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point [...]
Continued expansion of Pattern's IP portfolio Significant progress in expanding industry-leading oncology pipeline REDMOND, WA, June 12, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") announced at the Bio International Conference in San Diego that it is filing [...]
REDMOND, WA, May 22, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer (HGSOC) program. Armed with a [...]
REDMOND, WA, April 3, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, Matt Keener, CTO, and Nidhi Singh, Ph.D., Managing Director, Product Strategy/Sales will participate in the Life Science [...]
REDMOND, WA, January 2, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, is scheduled to present at the Biotech Showcase™ 2024 investor forum, taking place January 8-10, 2024 at [...]
REDMOND, WA, December 26, 2023 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, is scheduled to present at the J.P. Morgan 2024 Healthcare Conference on Thursday, January 11, 2024, at [...]
Grant from Defense Threat Reduction Agency includes purchase of Pattern's ProSpectral research platform REDMOND, WA, November 15, 2023 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Lawrence Berkeley National Laboratory (LBNL) and Los Alamos National Laboratory (LANL) [...]
Pattern Announces Promising In Vivo Antiproliferative Activity Against High-Grade Serous Ovarian Cancer with Two Novel Drug Combinations REDMOND, WA, June 13, 2023 -- Pattern Computer®, Inc. (Pattern), a leading AI-powered technology company dedicated to advancing innovative treatments for cancer, [...]